Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Caterina Zanette is active.

Publication


Featured researches published by Caterina Zanette.


International Archives of Occupational and Environmental Health | 2009

Nanoparticle dermal absorption and toxicity: a review of the literature

Matteo Crosera; Massimo Bovenzi; Giovanni Maina; Gianpiero Adami; Caterina Zanette; Chiara Florio; Francesca Larese

IntroductionNanotechnologies are among the fastest growing areas of scientific research and have important applications in a wide variety of fields. The data suggest that in the future workers and consumers exposed to nanoparticles will significantly increase.Dermal absorption and toxicity of nanoparticlesAt now there are gaps in understanding about the human and environmental risk that manufactured nanoparticles pose for occupational exposed people and for consumers. There is a need for assessing the health and environmental impacts, the nanoparticles life cycle, the human exposure routes, the behavior of nanoparticles in the body, and the risk for workers. Possible routes of entry into the body include inhalation, absorption through the skin or digestive tract, injection, and absorption or implantation for drugs delivery systems. In particular, dermal absorption and skin penetration of nanoparticles needs a better evaluation because few and contradictory data are present in the literature, mainly on titanium dioxide.ConclusionsThere are limited data on carbon-based nanoparticles and very few data on other metal nanoparticles increasingly used in industry. The article reviews the literature on the percutaneous absorption of nanoparticles and their effect on skin.


Journal of Medicinal Chemistry | 2009

Synthesis, Biological Evaluation, and Three-Dimensional in Silico Pharmacophore Model for σ1 Receptor Ligands Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives

Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Chiara Florio; Caterina Zanette; Maurizio Fermeglia; Paola Posocco; Maria Silvia Paneni; Sabrina Pricl; Luciano Vio

Novel benzo[d]oxazol-2(3H)-one derivatives were designed and synthesized, and their affinities against sigma receptors were evaluated. On the basis of 31 compounds, a three-dimensional pharmacophore model for the sigma(1) receptor binding site was developed using the Catalyst 4.9 software package. The best 3D pharmacophore hypothesis, consisting of one positive ionizable, one hydrogen bond acceptor, two hydrophobic aromatic, and one hydrophobic features provided a 3D-QSAR model with a correlation coefficient of 0.89. The best hypothesis was also validated by three independent methods, i.e., the Fisher randomization test included in the CatScramble functionality of Catalyst, the leave-one-out test, and activity prediction of an additional test set. The achieved results will allow researchers to use this 3D pharmacophore model for the design and synthesis of a second generation of high affinity sigma(1) ligands, as well as to discover other lead compounds for this class of receptors.


Toxicology in Vitro | 2011

Silver nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte HaCaT cell line.

Caterina Zanette; Marco Pelin; Matteo Crosera; Gianpiero Adami; Massimo Bovenzi; Francesca Larese; Chiara Florio

For their antibacterial activity, silver nanoparticles (Ag NPs) are largely used in various commercially available products designed to come in direct contact with the skin. In this study we investigated the effects of Ag NPs on skin using the human-derived keratinocyte HaCaT cell line model. Ag NPs caused a concentration- and time-dependent decrease of cell viability, with IC(50) values of 6.8 ± 1.3 μM (MTT assay) and 12 ± 1.2 μM (SRB assay) after 7 days of contact. A 24h treatment, followed by a 6 day recovery period in Ag NPs-free medium, reduced cell viability with almost the same potency (IC(50)s of 15.3 ± 4.6 and 35 ± 20 μM, MTT and SRB assays, respectively). Under these conditions, no evidence of induction of necrotic events (propidium iodide assay) was found. Apocynin, NADPH-oxidase inhibitor, or N(G)-monomethyl-L-argynine, nitric oxide synthase inhibitor, did not prevent NPs-induced reduction of cell viability. TEM analysis of cells exposed to NPs for 24h revealed alteration of nuclear morphology but only a marginal presence of individual NPs inside the cells. These results demonstrate that on HaCaT keratinocytes a relatively short time of contact with Ag NPs causes a long-lasting inhibition of cell growth, not associated with consistent Ag NPs internalization.


Bioorganic & Medicinal Chemistry Letters | 2010

A 3D-pharmacophore model for σ2 receptors based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives

Erik Laurini; Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Caterina Zanette; Chiara Florio; Paola Posocco; Maurizio Fermeglia; Sabrina Pricl

In this work we developed a 3D-pharmacophore model for sigma(2) receptor based on 19 benzooxazolone derivatives. The best 3D-pharmacophore hypothesis, consisting of five features: a positive ionizable, a hydrogen bond acceptor, a hydrophobic aromatic, a hydrophobic aliphatic, and a generic hydrophobic provided a 3D-QSAR model with a correlation coefficient of 0.97 and a RMSD of 0.48.


European Journal of Medicinal Chemistry | 2009

Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site

Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Caterina Zanette; Chiara Florio; Simona Collina; Daniela Rossi; Ornella Azzolina; Luciano Vio

We describe here the synthesis and the binding interaction with sigma(1) and sigma(2) receptors of a series of new benzo[d]oxazol-2(3H)-one derivatives variously substituted on the N-benzyl moiety. The results of binding studies confirm the notion that the benzoxazolone moiety confers preference towards sigma(1) sites and establish that the ability to bind to sigma(1), but not to sigma(2) receptors, is strongly affected by the kind and the position of the substituents introduced in the N-benzyl ring. In fact, compounds with substitutions in para-position with atoms of Cl, H or F or with a CH(3) group exhibit a higher affinity for sigma(1) receptors than the corresponding ortho-substituted compounds. The highest affinity and selectivity, with K(i) values of 0.1 and 427 nM for sigma(1) and sigma(2) receptors, respectively, and a corresponding K(i)sigma(2)/K(i)sigma(1) selectivity ratio of 4270 were found for the Cl-substituted compound. These results indicate that benzo[d]oxazol-2(3H)-one derivatives are among the most selective and sigma(1) receptor-preferring ligands currently available.


Bioorganic & Medicinal Chemistry | 2007

Design, synthesis and SAR analysis of novel selective σ1 ligands (Part 2)

Daniela Rossi; Mariangela Urbano; Alice Pedrali; Massimo Serra; Daniele Zampieri; Maria Grazia Mamolo; Christian Laggner; Caterina Zanette; Chiara Florio; Dirk Schepmann; Bernard Wuensch; Ornella Azzolina; Simona Collina

In order to investigate the molecular features involved in sigma receptors (sigma-Rs) binding, new compounds based on arylalkylaminoalcoholic, arylalkenyl- and arylalkylaminic scaffolds were synthesized and their affinity towards sigma(1)- and sigma(2)-Rs subtypes was evaluated. The most promising compounds were also screened for their affinity at micro-opioid, delta-opioid and kappa-opioid receptors. Biological results are herein presented and discussed.


European Journal of Medicinal Chemistry | 2008

Substituted benzylaminoalkylindoles with preference for the σ2 binding site

Maria Grazia Mamolo; Daniele Zampieri; Caterina Zanette; Chiara Florio; Simona Collina; Mariangela Urbano; Ornella Azzolina; Luciano Vio


XX National Meeting on Medicinal Chemistry | 2010

SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS.

Erik Laurini; Daniele Zampieri; Maria Grazia Mamolo; Luciano Vio; Paola Posocco; Maurizio Fermeglia; Sabrina Pricl; Caterina Zanette; Chiara Florio


XV Congresso Nazionale Società Italiana di Tossicologia | 2009

Effetto citotossico di nanoparticelle d'argento su cheratinociti umani HaCat in cultura

Caterina Zanette; Chiara Florio; Matteo Crosera; Gianpiero Adami; Massimo Bovenzi; Francesca Larese Filon


NMMC, XIX National Meeting on Medicinal Chemistry | 2008

3D pharmacophore model of σ1 binding site based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.

Erik Laurini; Maria Grazia Mamolo; Daniele Zampieri; Chiara Florio; Caterina Zanette; Sabrina Pricl; Maurizio Fermeglia; M. S. Panemi; Simona Collina; Daniela Rossi; Luciano Vio

Collaboration


Dive into the Caterina Zanette's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge